IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 73 filers reported holding IRADIMED CORP in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,647 | +6.3% | 83 | +6.4% | 0.00% | – |
Q1 2024 | $3,431 | +7.9% | 78 | +16.4% | 0.00% | – |
Q4 2023 | $3,180 | -80.5% | 67 | -81.7% | 0.00% | – |
Q3 2023 | $16,284 | -7.1% | 367 | 0.0% | 0.00% | – |
Q2 2023 | $17,521 | +125050.0% | 367 | 0.0% | 0.00% | – |
Q1 2023 | $14 | +40.0% | 367 | 0.0% | 0.00% | – |
Q4 2022 | $10 | -99.9% | 367 | +4.9% | 0.00% | – |
Q3 2022 | $11,000 | -56.0% | 350 | -52.4% | 0.00% | – |
Q2 2022 | $25,000 | -24.2% | 736 | 0.0% | 0.00% | – |
Q1 2022 | $33,000 | +13.8% | 736 | 0.0% | 0.00% | – |
Q4 2021 | $29,000 | -86.6% | 736 | -88.6% | 0.00% | -100.0% |
Q3 2021 | $217,000 | -19.0% | 6,466 | -29.1% | 0.00% | -50.0% |
Q2 2021 | $268,000 | +14.0% | 9,125 | 0.0% | 0.00% | +100.0% |
Q1 2021 | $235,000 | +13.0% | 9,125 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $208,000 | +235.5% | 9,125 | +213.7% | 0.00% | – |
Q3 2020 | $62,000 | – | 2,909 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Soleus Capital Management, L.P. | 234,810 | $5,013,000 | 5.83% |
Nine Ten Capital Management LLC | 277,088 | $5,916,000 | 2.51% |
RK Capital | 211,325 | $4,512,000 | 2.03% |
Parkman Healthcare Partners LLC | 113,855 | $2,431,000 | 1.13% |
Ranger Investment Management | 235,312 | $5,024,000 | 0.44% |
CADENCE CAPITAL MANAGEMENT LLC | 101,720 | $2,172,000 | 0.37% |
ALGERT GLOBAL LLC | 30,152 | $644,000 | 0.27% |
Mondrian Investment Partners LTD | 163,939 | $3,500,000 | 0.12% |
NAVELLIER & ASSOCIATES INC | 20,800 | $444,000 | 0.10% |
GLOBEFLEX CAPITAL L P | 15,510 | $331,000 | 0.10% |